High Impact Chronic Pain and UK Biobank: presentation, transitions, and targets for intervention (Chronic High Impact Pain Project, CHIPP)

High Impact Chronic Pain and UK Biobank: presentation, transitions, and targets for intervention (Chronic High Impact Pain Project, CHIPP)

Duration: 01 March 2022 – 28 February 2025
Funder: Medical Research Council and Versus Arthritis as part of the APDP initiative. 
Chief investigators: Professor Gary Macfarlane, Dr Elaine Wainwright
Post-doctoral research assistant: Dr Marcus Beasley

Up to half of adults in the UK have chronic pain. Many people with pain can function with minimal disruption. About a quarter of those with chronic pain though suffer disability and distress. This type of pain is high impact chronic pain. There isn't much research on this type of pain. This project aims to find out the causes of high impact chronic pain. It will assess why people develop it, and how they recover. This will tell us which population level interventions might reduce the impact of chronic pain.

The project is in three parts:

  1. Identifying groups of people with different patterns of high impact chronic pain
  2. Understanding why high impact chronic pain affects some people more than others
  3. Identifying population level interventions that can reduce the impact of chronic pain

The University of Aberdeen is leading the third part of this project. This part will take a public health perspective. We will find targets for prevention and treatment at the population level. We will summarize existing evidence on population level interventions that might help. We will then quantify how much we could reduce the impact of chronic pain by using them.

CHIPP is part of the Advanced Pain Discovery Platform (APDP).

If you have any queries about the study, you can contact the study team via email at epidemiology@abdn.ac.uk